Table 2 Clinical Characteristics of cystic prolactinomas patients
From: Operative treatment of cystic prolactinomas: a retrospective study
Features | Without preop- DA treatment | With preop- DA treatment | P values | ||
|---|---|---|---|---|---|
Patients’ preference (n = 12) | DA-intolerance (n = 5) | Persistent hyperprolactinemia (n = 13) | Inadequate tumor shrinkage (n = 11) | ||
Early postop remission (%) | 5 (41.67%) | 3 (60%) | 10 (76.92%) | 9 (81.82%) | 0.033 |
Follow-up remission (%) | 5 (41.67%) | 3 (60%) | 8 (61.54%) | 8 (72.73%) | 0.209 |
Total resection (%) | 10(83.33%) | 5 (100%) | 11 (84.62%) | 10 (90.91%) | 1.000 |